US Broker Ratings

Artivion, Inc. (AORT) Stock Analysis: Investors Eye 40.52% Potential Upside in Medical Device Innovator

Artivion, Inc. (AORT), a notable player in the healthcare sector specializing in medical devices, has captured investors’ attention with its promising growth trajectory and significant potential upside. With a current..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unpacking an 84.25% Potential Upside in the Spinal Devices Market

Alphatec Holdings, Inc. (ATEC) is making waves in the medical devices sector with its innovative approach to the surgical treatment of spinal disorders. Headquartered in Carlsbad, California, this healthcare company..

Immunocore Holdings plc (IMCR) Stock Analysis: A Biotech With Over 100% Potential Upside

Immunocore Holdings plc (NASDAQ: IMCR) stands out in the biotechnology sector, not just for its innovative approach to immunotherapies but also for the striking potential upside it offers to investors...

Arrowhead Pharmaceuticals (ARWR) Investor Outlook: Exploring the 27.49% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a beacon in the biotechnology industry, has been drawing attention with its remarkable growth trajectory and innovative pipeline. With a market capitalization of $8.94 billion,..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a Massive 89.92% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the U.S. healthcare sector, has recently captured the attention of investors with its impressive growth trajectory and substantial potential upside. With..

Neogen Corporation (NEOG) Stock Analysis: Navigating a 6.64% Potential Upside Amidst Financial Challenges

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s diagnostics and research industry, is positioning itself for growth despite current financial hurdles. With a market capitalization of $2.38..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring a 151% Upside Potential in Biotech

Dyne Therapeutics, Inc. (NASDAQ: DYN), a pioneering clinical-stage biotechnology company focusing on neuromuscular diseases, is generating buzz among investors with its robust growth potential. With a market capitalization of $2.56..

IDEAYA Biosciences, Inc. (IDYA) Stock Analysis: Exploring a 65% Upside Potential in Precision Oncology

IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a notable player in the biotech sector, specializes in precision medicine oncology with a focus on developing targeted therapeutics. With a current market cap of..

Teladoc Health, Inc. (TDOC) Stock Analysis: Unpacking a 92% Potential Upside for Investors

Teladoc Health, Inc. (NYSE: TDOC), a leading player in the virtual healthcare sector, presents an intriguing investment opportunity, boasting a potential upside of 92.08% from its current stock price of..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Unraveling the 78% Potential Upside in Biotechnology

Vera Therapeutics, Inc. (NASDAQ: VERA), a biotechnology company at the forefront of developing transformative treatments for serious immunological diseases, presents a compelling opportunity for investors seeking substantial upside potential. With..

Adaptive Biotechnologies (ADPT) Stock Analysis: Unpacking a 30% Upside Potential in Biotechnology

Adaptive Biotechnologies Corporation (ADPT), a prominent player in the healthcare sector, stands at the forefront of the biotechnology industry with its cutting-edge immune medicine platform. Headquartered in Seattle, Washington, this..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: 41.75% Upside Potential with Robust Analyst Ratings

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a notable player in the biotechnology sector, is capturing attention with its innovative approach to drug development. Specializing in small molecule therapeutics that leverage the..

Phreesia, Inc. (PHR) Stock Analysis: Unlocking a Potential Upside of Nearly 137%

Phreesia, Inc. (PHR) is a key player in the healthcare technology sector, providing an innovative Software-as-a-Service (SaaS) platform that streamlines patient intake and payment processes. As the healthcare industry increasingly..

NewAmsterdam Pharma (NAMS) Stock Analysis: Potential 41% Upside Beckons Investors Despite Current Challenges

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biopharmaceutical firm, is capturing investor interest with its promising yet challenging financial landscape. Specializing in the development of therapies for metabolic diseases,..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a Potential 225.8% Upside in the Biotech Sector

As ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) captures investor attention, the biotech firm presents a compelling case for those looking to capitalize on significant potential upside. Specializing in innovative treatments for..

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Bold Bet with 131.99% Potential Upside

Celldex Therapeutics, Inc. (NASDAQ: CLDX) stands out in the biotechnology sector, leveraging its innovative approach in developing therapeutic antibodies targeting severe inflammatory and autoimmune diseases. With a market capitalization of..

Privia Health Group, Inc. (PRVA) Stock Analysis: A Promising 39.57% Upside Potential

Privia Health Group, Inc. (NASDAQ: PRVA) is attracting significant attention from investors in the healthcare sector due to its robust growth prospects and impressive analyst ratings. As a leader in..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 28% Upside Potential

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically within the medical care facilities industry, is gaining considerable attention from investors looking for growth opportunities...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: A High-Yield Dividend Play Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the medical instruments and supplies industry, stands out with its attractive dividend yield of 4.94%. However, investors should weigh this income..

Omnicell, Inc. (OMCL) Investor Outlook: Exploring a Potential 57.34% Upside

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, is capturing investor attention with its compelling growth potential amidst a challenging market landscape. As a leading provider of..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds